LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

Search

CareDx Inc

Cerrado

SectorSalud

17.77 0.17

Resumen

Variación precio

24h

Actual

Mínimo

17.54

Máximo

17.79

Métricas clave

By Trading Economics

Ingresos

10M

1.7M

Ventas

13M

100M

P/B

Media del Sector

14.031

79.874

Margen de beneficio

1.674

Empleados

644

EBITDA

11M

6.8M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+34.76% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

170M

956M

Apertura anterior

17.6

Cierre anterior

17.77

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

165 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

CareDx Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

28 nov 2025, 15:29 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

China's Jiangxi Copper Rejected by SolGold in $1 Billion Takeover Approach

28 nov 2025, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

28 nov 2025, 19:59 UTC

Charlas de Mercado

Oil Futures Settle Lower in Slow Black Friday Trade -- Market Talk

28 nov 2025, 19:47 UTC

Charlas de Mercado

U.S. Natural Gas Lifted By Cold Weather Outlook -- Market Talk

28 nov 2025, 18:16 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

28 nov 2025, 18:16 UTC

Charlas de Mercado

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov 2025, 18:08 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

28 nov 2025, 18:08 UTC

Charlas de Mercado

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov 2025, 17:48 UTC

Charlas de Mercado

Bank of Canada May Revise Up Inflation Projections After GDP Data -- Market Talk

28 nov 2025, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

28 nov 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Week's Best: Sieg's Stature at Citi Grows -- Barrons.com

28 nov 2025, 15:51 UTC

Charlas de Mercado

Canada Household Spending Edges Lower -- Market Talk

28 nov 2025, 15:33 UTC

Charlas de Mercado

Crude Futures Gain as U.S. Market Reopens -- Market Talk

28 nov 2025, 15:21 UTC

Charlas de Mercado

Gold Rises on U.S. Rate-Cut Bets After CME Outage -- Market Talk

28 nov 2025, 15:13 UTC

Charlas de Mercado

Dollar Recovers Slightly as Investors Already Price in Fed Rate Cut -- Market Talk

28 nov 2025, 15:11 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

28 nov 2025, 15:11 UTC

Charlas de Mercado

Canadian National Railway Showing Positive Trend Going Into 2026 -- Market Talk

28 nov 2025, 14:51 UTC

Charlas de Mercado

Canada GDP Report Masks Fragile State of Economy -- Market Talk

28 nov 2025, 14:41 UTC

Charlas de Mercado

Canada's GDP Level Pulled Higher by 'Eye-Opening' Revisions -- Market Talk

28 nov 2025, 14:37 UTC

Charlas de Mercado

U.S. Natural Gas Futures Rise As Temperatures Drop -- Market Talk

28 nov 2025, 14:33 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

28 nov 2025, 14:33 UTC

Charlas de Mercado

Steep Import Drop Fuels Surprise Lift in Canada GDP -- Market Talk

28 nov 2025, 14:20 UTC

Charlas de Mercado

Too Much Noise in Canada's Surprise 3Q GDP Gain -- Market Talk

28 nov 2025, 14:10 UTC

Charlas de Mercado

Canadian Nowcast Came Closest to Predicting Surprise 3Q Strength -- Market Talk

28 nov 2025, 13:39 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

28 nov 2025, 13:39 UTC

Charlas de Mercado

Canada Trade Data Could Face Larger-Than-Normal Revisions -- Market Talk

28 nov 2025, 13:36 UTC

Charlas de Mercado

Canada's Economy Expands More Than Expected -- Market Talk

28 nov 2025, 13:29 UTC

Charlas de Mercado

CME Outage Sowing Chaos Across Markets, Trade Nations Says -- Market Talk

28 nov 2025, 13:27 UTC

Charlas de Mercado

Russia-Ukraine Peace Efforts to Have Little Impact on Oil Fundamentals -- Market Talk

28 nov 2025, 13:19 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparación entre iguales

Cambio de precio

CareDx Inc Esperado

Precio Objetivo

By TipRanks

34.76% repunte

Estimación a 12 meses

Media 24 USD  34.76%

Máximo 26 USD

Mínimo 22 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CareDx Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

14.77 / 18.49Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

165 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat